Overview
Our investment focus is on biotech companies that demonstrate breakthrough technologies or solutions in healthcare. We are ready to invest amounts ranging from $200,000 to $5 million per project, depending on the growth stage and potential impact of the company. We prioritize teams with a clear vision, scalable business models, and a strong proof of concept. Our goal is to partner with skilled founders and operators who are poised to disrupt the market and deliver real value in life sciences.
Investor profile
David R. Mitchell, an experienced investor passionate about advancing healthcare through innovation. Our fund specializes in early to growth-stage biotech investments, with a strong mandate for value creation and a hands-on approach to supporting portfolio companies.
Requirements
Startups should have a validated product or service, a capable and committed leadership team, and a clear pathway to commercialization. Evidence of market demand and a solid business strategy are essential.
Open investor offer
Open this investor offer to get access to investor contact details and continue communication with the investor.